myEndometrialCancerTeam

The median survival time for recurrent or advanced endometrial cancer is typically 12 to 15 months, meaning half of patients live longer than this timeframe. The location where cancer returns can significantly impact survival rates.

For example, when cancer returns in the pelvic area, there is approximately a 73% chance of Show Full Answer

The median survival time for recurrent or advanced endometrial cancer is typically 12 to 15 months, meaning half of patients live longer than this timeframe. The location where cancer returns can significantly impact survival rates.

For example, when cancer returns in the pelvic area, there is approximately a 73% chance of surviving three years. If the cancer has spread to other areas like the lungs, the three-year survival rate is around 38%. However, it's important to know that new treatments are continuously improving outcomes for people with recurrent endometrial cancer. Clinical trials exploring immunotherapies and targeted therapies are showing promise in helping patients live longer, healthier lives. Your oncologist can discuss whether you might be eligible for these emerging treatment options.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Recurrent Endometrial Cancer: Treatments, Life Expectancy, and More